MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from initial
public offering, net of...
$202,071K
Exercise of common stock
options
$3,639K
Net cash provided by
financing activities
$205,710K
Net increase
(decrease) in cash, cash...
$20,664K
Canceled cashflow
$185,046K
Maturities of marketable
securities
$206,653K
Stock-based compensation
expense
$12,066K
Accrued expenses and
other current...
$1,975K
Non-cash operating lease
expense
$1,962K
Depreciation expense
$647K
Net cash used in
investing activities
-$118,749K
Net cash used in
operating activities
-$66,297K
Canceled cashflow
$206,653K
Canceled cashflow
$16,650K
Purchases of marketable
securities
$325,025K
Net loss
-$75,268K
Purchases of property and
equipment
$377K
Amortization of discount on
marketable securities
$3,052K
Operating lease liability
-$2,128K
Prepaid expenses and
other current assets
$2,082K
Accounts payable
-$417K
Back
Back
Cash Flow
source: myfinsight.com
Sionna Therapeutics, Inc. (SION)
Sionna Therapeutics, Inc. (SION)